Capecitabine + Radiotherapy

COMBINATION_PRODUCT2 trials

Sponsors

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Vastra Gotaland Region

Conditions

Rectal Cancer

Phase 2

Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer

CompletedNCT01043484

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Rectal Cancer

Start: 2009-12-31End: 2016-08-31Updated: 2016-10-19

Phase 4

Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer

Not yet recruitingNCT07483060

Vastra Gotaland RegionRectal Cancer

Start: 2026-03-12End: 2031-12-01Target: 90Updated: 2026-03-19

Related Papers

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results

BMC Cancer2020-11-2715 citations

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

2015-02-2629 citations